Key facts
- This page summarizes Jack Phillips's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 13 Mar 2023, 17:46.
Jack Phillips - 08 Mar 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Signature
- /s/ Steven Reichling, attorney-in-fact
- Issuer symbol
- AXDX
- Transactions as of
- 08 Mar 2023
- Net transactions value
- -$73,148
- Form type
- 4
- Filing time
- 13 Mar 2023, 17:46:08 UTC
- Previous filing
- 15 Feb 2023
- Next filing
- 15 Mar 2023
- SEC
- View on sec.gov
Key filing fact
Jack Phillips filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 13 Mar 2023.
Change
- Previous filing in this sequence was filed on 15 Feb 2023.
- Current net transaction value: -$73,148.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +350,000
- Change %
- +130%
- Price
- $0.000000
- Shares after
- 619,458
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
AXDX
transaction
Common Stock
Sale
- Transaction value
- $73,148
- Shares
- -155,635
- Change %
- -25%
- Price
- $0.4700
- Shares after
- 463,823
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -350,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 350,000
- Exercise price
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. |
| F2 | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |